Skip to main content

Table 3 Random sample; number of prescriptions, therapy groups and clinical evaluation

From: Medication prescribing for asthma and COPD: a register-based cross-sectional study in Swedish primary care

Treatment

Total

Recorded asthma diagnosis

Recorded COPD diagnosis

Provisional diagnoses

Trial by medication

Off-label prescribing

 

n

n (%)

n (%)

n (%)

n (%)

n (%)

All patients

670

320 (48)

71 (11)

44 (7)

85 (13)

150 (22)

Number of prescriptions 1

      

 1 prescription

332

135 (42)

22 (31)

25 (57)

34 (40)

116 (77)

 2 prescriptions

196

117 (37)

16 (23)

15 (34)

26 (31)

22 (15)

  ≥ 3 prescriptions

142

68 (21)

33 (46)

4 (9)

25 (29)

12 (8)

Therapy groups 2

      

 SABA only

207

54 (17)

15 (21)

14 (32)

29 (34)

95 (63)

 ICS and SABA

141

83 (26)

7 (10)

13 (30)

24 (28)

14 (9)

 ICS and LABA

91

55 (17)

12 (17)

7 (16)

6 (7)

11 (7)

 Fixed combination of ICS/LABA

175

102 (32)

34 (48)

8 (18)

17 (20)

14 (9)

 ICS only3

56

26 (8)

3 (4)

2 (5)

9 (11)

16 (11)

Clinical evaluation

      

 PEF4 only

36

25 (8)

1 (1)

1 (2)

2 (2)

7 (5)

 Spirometry

207

110 (34)

37 (52)

16 (36)

24 (28)

20 (13)

  1. 1Number of prescriptions = number of occasions where the patient had one or more medications prescribed.
  2. 2Therapy groups according to the treatment steps in the therapy recommendations, SABA = Short acting β2-agonists; LABA = Long-acting β2- agonists; ICS = Inhaled Corticosteroids.
  3. 3ICS is not recommended as monotherapy.
  4. 4PEF = Peak Expiratory Flow.